{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "LLLT",
      "Major depressive disorder",
      "NIR",
      "Photobiomodulation",
      "Transcranial photobiomodulation",
      "Treatment-resistant depression"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37149348",
  "DateCompleted": {
    "Year": "2023",
    "Month": "05",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "06",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "03",
        "Day": "25"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.psc.2023.02.013",
      "S0193-953X(23)00025-4"
    ],
    "Journal": {
      "ISSN": "1558-3147",
      "JournalIssue": {
        "Volume": "46",
        "Issue": "2",
        "PubDate": {
          "Year": "2023",
          "Month": "Jun"
        }
      },
      "Title": "The Psychiatric clinics of North America",
      "ISOAbbreviation": "Psychiatr Clin North Am"
    },
    "ArticleTitle": "Photobiomodulation: An Emerging Treatment Modality for Depression.",
    "Pagination": {
      "StartPage": "331",
      "EndPage": "348",
      "MedlinePgn": "331-348"
    },
    "Abstract": {
      "AbstractText": [
        "Major depressive disorder (MDD) is considered a global crisis. Conventional treatments for MDD consist of pharmacotherapy and psychotherapy, although a significant number of patients with depression respond poorly to conventional treatments and are diagnosed with treatment-resistant depression (TRD). Transcranial photobiomodulation (t-PBM) therapy uses near-infrared light, delivered transcranially, to modulate the brain cortex. The aim of this review was to revisit the antidepressant effects of t-PBM, with a special emphasis on individuals with TRD. A search on PubMed and ClinicalTrials.gov tracked clinical studies using t-PBM for the treatment of patients diagnosed with MDD and TRD."
      ],
      "CopyrightInformation": "Copyright \u00a9 2023 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital (MGH), 149 13th Street (2612), Boston, MA 02129, USA; Department of Psychiatry, Harvard Medical School (HMS), 25 Shattuck Street, Boston, MA 02115, USA; Department of Anatomy, Institute of Biomedical Sciences (ICB), University of Sao Paulo (USP), 2415 Prof. Lineu Prestes Avenue, Sao Paulo, SP 05508-000, Brazil."
          }
        ],
        "LastName": "Vieira",
        "ForeName": "Willians Fernando",
        "Initials": "WF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinical Research Division, Nathan Kline Institute (NKI) for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA; Department of Psychiatry, New York University (NYU) School of Medicine, 550 First Avenue, New York, NY 10016, USA."
          }
        ],
        "LastName": "Iosifescu",
        "ForeName": "Dan V",
        "Initials": "DV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital (MGH), 149 13th Street (2612), Boston, MA 02129, USA."
          }
        ],
        "LastName": "McEachern",
        "ForeName": "Kayla Marie",
        "Initials": "KM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital (MGH), 149 13th Street (2612), Boston, MA 02129, USA."
          }
        ],
        "LastName": "Gersten",
        "ForeName": "Maia",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital (MGH), 149 13th Street (2612), Boston, MA 02129, USA; Department of Psychiatry, Harvard Medical School (HMS), 25 Shattuck Street, Boston, MA 02115, USA. Electronic address: pcassano@mgh.harvard.edu."
          }
        ],
        "LastName": "Cassano",
        "ForeName": "Paolo",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Psychiatr Clin North Am",
    "NlmUniqueID": "7708110",
    "ISSNLinking": "0193-953X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Brain"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychotherapy"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Depressive Disorder, Treatment-Resistant"
    }
  ]
}